AnalystsWill SoghikianWill Soghikian's Stock Forecasts
AnalystsWill Soghikian
Sectors:
Industries:
Analyst Ranking
Bottom 38%
#3449 out of 5539 analysts
Average Return
0%
Win Rate
0%0 out of 5
Risk vs Reward
Poor
Good
Will Soghikian's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Q32 Bio IncQTTB | 0.00% | $8.74 | $8.74 | 2026-10-12 - 2026-10-12 | Buy |
Equillium IncEQ | 0.00% | $1.50 | $1.50 | 2026-10-12 - 2026-10-12 | Buy |
Protagonist Therapeutics IncPTGX | 0.00% | $144.88 | $144.88 | 2026-10-12 - 2026-10-12 | Buy |
Nektar TherapeuticsNKTR | 0.00% | $39.84 | $39.84 | 2026-10-12 - 2026-10-12 | Buy |
Connect Biopharma Holdings LtdCNTB | 0.00% | $0.91 | $0.91 | 2026-10-12 - 2026-10-12 | Buy |
Will Soghikian Analyst Color
Get additional color on Will Soghikian's coverage of popular stocks
Will Soghikian's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Protagonist Therapeutics IncPTGX | 1 | Buy | $190.00 | +31.14% | Assumes | a day ago |
Equillium IncEQ | 1 | Buy | $6.00 | +300.00% | Assumes | a day ago |
Connect Biopharma Holdings LtdCNTB | 1 | Buy | $4.00 | +341.50% | Assumes | a day ago |
Q32 Bio IncQTTB | 1 | Buy | $40.00 | +357.67% | Initiates Coverage On | a day ago |
Vera Therapeutics IncVERA | 1 | Hold | $34.00 | +22.66% | Initiates Coverage On | a day ago |
Nektar TherapeuticsNKTR | 1 | Buy | $130.00 | +226.31% | Initiates Coverage On | a day ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.